Chidozie Ugwumba sold $1.7M of CLNN
owner at Clene Inc.. 257,795 shares at an average of $6.69, traded Dec 3, 2025, filed Dec 18, 2025.
Score components
- +12Role10% owner
- +25Trade size$1.7M at market
- +10Share of holdings soldSold 40% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -16.4%, 3m -2.8%, 6m -0.5%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001835544-25-000002, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 3, 2025 | SOpen-market sale Common Stockindirect: By Symbiosis II, LLC | -56,577 | $7.86 | $445k | 594,368 | Dec 18, 2025 |
| Dec 4, 2025 | SOpen-market sale Common Stockindirect: By Symbiosis II, LLC | -72,748 | $6.73 | $490k | 521,620 | Dec 18, 2025 |
| Dec 5, 2025 | SOpen-market sale Common Stockindirect: By Symbiosis II, LLC | -37,235 | $5.94 | $221k | 484,385 | Dec 18, 2025 |
| Dec 8, 2025 | SOpen-market sale Common Stockindirect: By Symbiosis II, LLC | -21,463 | $5.70 | $122k | 462,922 | Dec 18, 2025 |
| Dec 9, 2025 | SOpen-market sale Common Stockindirect: By Symbiosis II, LLC | -15,031 | $5.95 | $89k | 447,891 | Dec 18, 2025 |
| Dec 10, 2025 | SOpen-market sale Common Stockindirect: By Symbiosis II, LLC | -9,921 | $6.42 | $64k | 437,970 | Dec 18, 2025 |
| Dec 11, 2025 | SOpen-market sale Common Stockindirect: By Symbiosis II, LLC | -10,907 | $6.81 | $74k | 427,063 | Dec 18, 2025 |
| Dec 12, 2025 | SOpen-market sale Common Stockindirect: By Symbiosis II, LLC | -7,603 | $6.79 | $52k | 419,460 | Dec 18, 2025 |
| Dec 15, 2025 | SOpen-market sale Common Stockindirect: By Symbiosis II, LLC | -10,580 | $6.49 | $69k | 408,880 | Dec 18, 2025 |
| Dec 16, 2025 | SOpen-market sale Common Stockindirect: By Symbiosis II, LLC | -7,030 | $6.31 | $44k | 401,850 | Dec 18, 2025 |
| Dec 17, 2025 | SOpen-market sale Common Stockindirect: By Symbiosis II, LLC | -2,884 | $6.61 | $19k | 398,966 | Dec 18, 2025 |
| Dec 18, 2025 | SOpen-market sale Common Stockindirect: By Symbiosis II, LLC | -5,816 | $6.33 | $37k | 393,150 | Dec 18, 2025 |
Related signals
Other insiders at Clene Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 41Moderate | CLNNsell Clene Inc. | Chidozie Ugwumba owner | $604k 95,473 shares | -48% | |
| 40Moderate | CLNNsell Clene Inc. | Chidozie Ugwumba owner | $530k 78,679 shares | -28% | |
| 22Weak | CLNNsell Clene Inc. | Chidozie Ugwumba owner | $113k 19,497 shares | -7% | |
| 33Weak | CLNNsell Clene Inc. | Chidozie Ugwumba owner | $403k 65,663 shares | -18% | |
| 25Weak | CLNNsell Clene Inc. | Chidozie Ugwumba owner | $252k 39,162 shares | -10% | |
| 22Weak | CLNNsell Clene Inc. | Chidozie Ugwumba owner | $120k 24,925 shares | -6% | |
| 12Weak | CLNNsell Clene Inc. | Chidozie Ugwumba owner | $21k 4,278 shares | -1% | |
| 35Weak | CLNNsell Clene Inc. | Chidozie Ugwumba owner | $494k 100,997 shares | -19% | |
| 22Weak | CLNNsell Clene Inc. | Chidozie Ugwumba owner | $100k 17,909 shares | -3% | |
| 12Weak | CLNNsell Clene Inc. | Chidozie Ugwumba owner | $23k 5,559 shares | -1% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.